TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Phibro Animal Health Corporation (PAHC)

Healthcare Drug Manufacturers - Specialty & Generic
37.20 $
+2.3% vs. previous close
Closing price · As of: 3. Aug 2026

Phibro Animal Health Corporation (PAHC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 384 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement PAHC
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
255 231 250 263 273 260 309 348 379 364 374 384 1,500
178 164 171 184 186 177 207 243 269 244 241 258 1,012
77 68 79 80 87 83 102 105 110 120 133 125 487
24 29 24
53 69 63 60 69 66 76 71 76 69 82 81 308
53 68 63 60 69 66 76 71 76 71 78 77 303
24 -0.7 16 20 18 18 26 34 34 48 54 48 184
8.8 9.2 9.4 9.3 5.7 8.2 9.2 13 8.5 13 13 11 46
21 -12 3.6 13 6.4 9.6 4.8 30 24 36 36 32 129
9.9 -4.0 2.3 4.5 5.7 2.6 1.7 8.8 6.6 9.7 9.0 8.3 34
11 -8.0 1.3 8.4 0.8 7.0 3.2 21 17 27 27 24 95
35 2.2 18 28 21 27 26 51 45 63 62 56 225

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?